Table 4 % inhibition and IC50 against α amylase and α-glucosidase.

From: The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approach

Compound

α-glucosidase

α-amylase

% inhibition

IC50 (µM)

% inhibition

IC50 (µM)

S1

55 ± 0.047

3.91

46 ± 0.091

8.89

Acarbose

37 ± 0.026

58.8

33 ± 0.042

28.5

Back to article page